UMIN000048296
Phase II clinical trial to evaluate the safety and efficacy of particle radiotherapy preceded atezolizumab plus bevacizumab treatment in patients with unresectable multiple hepatocellular carcinoma
Kobe University·University Hospital Medical Information Network·drugRecruiting
Study focus
- Disease/Condition
- Hepatocellular carcinoma
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Kobe University
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Apr 01, 2023
- End date
- N/A
ICD-10 classifications
Malignant neoplasm: HepatoblastomaMalignant neoplasm: Liver cell carcinomaMalignant neoplasm: Other specified carcinomas of liverMalignant neoplasm: Liver, unspecifiedMalignant neoplasm: Hepatic flexure
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000048296
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000048296 through Pure Global AI's free database. This phase not specified trial is sponsored by Kobe University and is currently Recruiting. The study focuses on Hepatocellular carcinoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.